These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Introduction to the concept of signal toxicity. Kanno J J Toxicol Sci; 2016; 41(Special):SP105-SP109. PubMed ID: 28413182 [TBL] [Abstract][Full Text] [Related]
26. Precision of estimates of an ADI (or TDI or PTWI). Speijers GJ Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619 [TBL] [Abstract][Full Text] [Related]
27. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective. Buckley LA; Dorato MA Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212 [TBL] [Abstract][Full Text] [Related]
28. Toxicokinetics in the National Toxicology Program. Goehl TJ NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193 [TBL] [Abstract][Full Text] [Related]
29. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment. Andersen ME Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672 [TBL] [Abstract][Full Text] [Related]
30. Toxicology of chemical mixtures: challenges for today and the future. Feron VJ; Groten JP; Jonker D; Cassee FR; van Bladeren PJ Toxicology; 1995 Dec; 105(2-3):415-27. PubMed ID: 8571377 [TBL] [Abstract][Full Text] [Related]
31. [Toxicogenomics in hazard assessment of chemicals]. Kostka G; Liszewska M; Urbanek-Olejnik K Rocz Panstw Zakl Hig; 2010; 61(2):119-27. PubMed ID: 20839457 [TBL] [Abstract][Full Text] [Related]
33. [Evidence-based toxicological evaluation of chemicals by group summaries]. Greim H Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1417-25. PubMed ID: 19137217 [TBL] [Abstract][Full Text] [Related]
34. Background of REACH in EU regulations on evaluation of chemicals. Foth H; Hayes A Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197 [TBL] [Abstract][Full Text] [Related]
35. Toxicokinetics, dose-response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives. Chen Q; Riviere JE; Lin Z Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1808. PubMed ID: 36416026 [TBL] [Abstract][Full Text] [Related]
36. Chemical quandary: chemicals are essential to our way of life, but who's ensuring their safe use? Farquhar D State Legis; 2014 Dec; 40(10):32-4. PubMed ID: 25556254 [No Abstract] [Full Text] [Related]
37. Safety and toxicology assessment of sodium nitrite administered by intramuscular injection. Miller L; Hébert CD; Grimes SD; Toomey JS; Oh JY; Rose JJ; Patel RP Toxicol Appl Pharmacol; 2021 Oct; 429():115702. PubMed ID: 34464673 [TBL] [Abstract][Full Text] [Related]
38. Food and Drug Administration viewpoints on toxicokinetics: the view from review. DeGeorge JJ Toxicol Pathol; 1995; 23(2):220-5. PubMed ID: 7569678 [TBL] [Abstract][Full Text] [Related]
39. Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes. Malloy T; Zaunbrecher V; Beryt E; Judson R; Tice R; Allard P; Blake A; Cote I; Godwin H; Heine L; Kerzic P; Kostal J; Marchant G; McPartland J; Moran K; Nel A; Ogunseitan O; Rossi M; Thayer K; Tickner J; Whittaker M; Zarker K Integr Environ Assess Manag; 2017 Sep; 13(5):915-925. PubMed ID: 28247928 [TBL] [Abstract][Full Text] [Related]